Streetbeat News

Corporate News

SFTBY

OpenAI is close to finalizing a massive $40 billion funding round led by SoftBank, with potential participation from other investors like Magnetar Capital, Coatue Management, Founders Fund, and Altimeter Capital Management. The round is expected to elevate the company's valuation to $300 billion, following its previous $6.6 billion round in October 2024.

Portfolio Pulse from

March 27, 2025 | 6:30 am

HYPRO

HydrogenPro, a Norwegian company listed on the Oslo Stock Exchange, has received a purchase order for high-pressure alkaline electrolyzers from an undisclosed customer. The order is valued at USD 2.5 million, with manufacturing scheduled to start in early May 2025.

Portfolio Pulse from

March 27, 2025 | 6:30 am

HYPRO

HydrogenPro, a Norwegian company listed on the Oslo Stock Exchange, has received a purchase order for high-pressure alkaline electrolyzers valued at $2.5 million from an undisclosed customer. Manufacturing of the electrolyzers is scheduled to begin in early May 2025, indicating continued demand in the green hydrogen sector.

Portfolio Pulse from

March 27, 2025 | 6:30 am

IDRSF

Idorsia's 2024 Annual Report highlights key strategic developments including accelerating QUVIVIQ sales in Europe, FDA approval of aprocitentan (TRYVIO) for hypertension, and financial restructuring to secure operations through 2026. The company aims to reach commercial profitability with QUVIVIQ in 2026 and overall profitability in 2027.

Portfolio Pulse from

March 27, 2025 | 6:15 am

AMZN

The article suggests that Amazon's current stock price represents an exceptional investment opportunity, highlighting the company's robust $2 trillion market valuation and diverse business model spanning e-commerce, cloud services, subscriptions, and advertising.

Portfolio Pulse from

March 27, 2025 | 6:15 am

IDRSF

Idorsia's 2024 Annual Report reveals strategic progress in commercializing QUVIVIQ in Europe and launching TRYVIO (aprocitentan) for hypertension. The company aims to achieve commercial profitability with QUVIVIQ in 2026 and overall profitability in 2027. Key developments include partnerships with Viatris for selatogrel and cenerimod, and restructuring of convertible bond debt to secure operations into 2026.

Portfolio Pulse from

March 27, 2025 | 6:15 am

GME

MSTR

GameStop's board unanimously approved adopting Bitcoin reserves, following strategies similar to MicroStrategy. With $4.6 billion in cash reserves, the company plans to potentially acquire Bitcoin through debt and stock issuance. The announcement caused mixed market reactions, with the stock initially rising 10% after the news.

Portfolio Pulse from

March 27, 2025 | 6:15 am

HYMTF

Hyundai ADM Bio has demonstrated significant anti-metastatic efficacy of its novel drug Penetrium in preclinical studies for triple-negative breast cancer (TNBC). The drug uniquely targets the extracellular matrix (ECM), potentially overcoming traditional chemotherapy limitations by softening therapy-hardened barriers and preventing metastasis. Combination therapy with paclitaxel reduced tumor size by 36.22% and metastasis by 85.78% in mouse models.

Portfolio Pulse from

March 27, 2025 | 5:45 am

AEDFF

Aedifica NV/SA, a public regulated real estate company listed on Euronext Brussels and Euronext Amsterdam, has issued a press release announcing its Ordinary General Meeting scheduled for Tuesday, 13 May 2025.

Portfolio Pulse from

March 27, 2025 | 5:45 am

BTCUSD

The Blockchain Group (TBG), a French publicly listed blockchain solutions company, has purchased 580 BTC for €47.3 million, expanding its cryptocurrency holdings. The company reported an extraordinary 709.8% Bitcoin yield year-to-date, positioning itself as a leading European Bitcoin treasury. TBG's CEO emphasizes their commitment to Bitcoin as the future of finance.

Portfolio Pulse from

March 27, 2025 | 5:45 am